COVID-19: ECDC updates case definition for EU surveillance
Following the rapid increase of coronavirus cases in Italy, ECDC continuously assesses the impact that those local clusters have on the overall risk of further spread in the EU/EEA. In addition, the Centre supports the Member States in their COVID-19 preparedness and response efforts.
ECDC statement on the rapid increase of COVID-19 cases in Italy
In the last 24 hours, the Italian Ministry of Health confirmed an increasing number of COVID-19 cases, including two deaths, clustered in two regions in Northern Italy as well as single cases in other regions in Northern Italy.
Novel coronavirus: three cases reported in France
The first confirmed cases in Europe are not unexpected. The fact that these cases were identified, proves that detection and confirmation of this novel virus is working in France, showing a high level of preparedness to prevent and control possible infections of 2019-nCoV.
Update: Cluster of pneumonia cases associated with novel coronavirus – Wuhan, China – 2019
As of 13th January 2020, 59 probable cases of pneumonia associated with a novel coronavirus have been reported in Wuhan City, China. Most cases had an epidemiological link to a Seafood City market (a wholesale market for seafood and live animals).
Epidemiological update: Ongoing outbreak of cholera in Cuba, potential risk for European travellersArchived
On 3 July the Cuban Ministry of Health confirmed an outbreak of cholera in the south-western city of Manzanillo. It is the first time in almost 150 years that an outbreak of cholera is reported in the island.
Risk of travel-associated cholera transmission can remain low if precautionary measures are takenArchived
ECDC has issued a risk assessment on cholera transmission related to travel to the Dominican Republic after two cases have been detected in tourists returning to the UK and Germany from resorts in the Punta Cana area of the Dominican Republic.
Imported methicillin-resistant Staphylococcus aureus, SwedenArchived
The authors analyzed data on 444 imported cases of methicillin-resistant Staphylococcus aureus (MRSA) in Sweden during the period 2000-2003. The risk for MRSA carriage or infection in returning travellers ranged from 0.1 per million travellers returning from Nordic countries to 59.4 per million travellers returning from North Africa and the Middle East.